(Q39763049)

14 September 2017

title

Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States (English)

1 reference

14 September 2017

0 references

head and neck carcinoma

1 reference

3

Adam S Garden

1 reference

14 September 2017

9

K Kian Ang

1 reference

14 September 2017

Stuart J Wong

1

1 reference

14 September 2017

Paul M Harari

2

1 reference

14 September 2017

Marc Schwartz

4

1 reference

14 September 2017

Lisa Bellm

5

1 reference

14 September 2017

Amy Chen

6

1 reference

14 September 2017

Walter J Curran

7

1 reference

14 September 2017

Barbara A Murphy

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

8 November 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

117

1 reference

14 September 2017

issue

8

1 reference

14 September 2017

page(s)

1679-1686

1 reference

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

inferred from DOI database lookup

7 January 2021

based on heuristic

Redefining the role of induction chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25721

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.25721

1 reference

14 September 2017

1 reference